医药经济报报道
转型中的生物制药梦想
2010.3.29

Summary: This is a feature on Bristol-Myers Squibb. Bristol-Myers Squibb (Shanghai) was established in 1985. It has become an important branch of BMS. In March, Dr. Elliot Sigal, head of research and development, visited China. "Five potential new medicines could be introduced in the next three years," Dr. Elliot Sigal said during an interview. BMS invested $3.5b in R&D in 2009, accounting for 20% of the company's sales volume.

点击小图看大图